Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly

Autor: Stephen C. Hammill, Win Kuang Shen, Naser M. Ammash, Paul A. Friedman, Brenda S. Moon, Ahmad A. Elesber, Bernard J. Gersh, Regina M. Herges, Virend K. Somers, Ana G Rosales, Joseph F. Malouf, David O. Hodge
Rok vydání: 2006
Předmět:
Zdroj: European Heart Journal. 27:854-860
ISSN: 1522-9645
0195-668X
Popis: Aims Trials of rate control vs. rhythm control for atrial fibrillation or flutter included few patients with new-onset arrhythmia. Our objective was to assess the relapse rate and the effect of the relapse of newonset atrial arrhythmias on mortality after direct-current cardioversion (DCCV). Methods and results A cohort of 351 patients with atrial fibrillation (new onset in 179) and 126 patients with atrial flutter (new onset in 78) was followed-up after DCCV. Cox proportional hazard models were used. Median age was 74.6 years. Mean follow-up for relapse was 7.7 months; for death, 29.4 months. Patients with new-onset atrial flutter [adjusted hazard ratio (HR) ¼ 1] were more likely to maintain sinus rhythm than the patients with recurrent atrial flutter (adjusted HR ¼ 2.5, P , 0.01), new-onset atrial fibrillation (adjusted HR ¼ 2.4, P , 0.01), or recurrent atrial fibrillation (adjusted HR ¼ 2.7, P , 0.01). Patients with new-onset atrial fibrillation were as likely to have relapses as patients with recurrent atrial fibrillation or flutter. Relapse of atrial arrhythmia after DCCV was associated with increased mortality (adjusted HR ¼ 3.1, P , 0.01). Conclusion DCCV is more successful in maintaining sinus rhythm in patients with new-onset atrial flutter than in patients with new-onset atrial fibrillation. Relapse of atrial arrhythmia after cardioversion is associated with increased mortality.
Databáze: OpenAIRE